Evidence map›Paper›PMID 19772887›Full record

ArticleExperimental hematology2009

Inducible transgenes under the control of the hCD68 promoter identifies mouse macrophages with a distribution that differs from the F4/80 - and CSF-1R-expressing populations.

Manoj M Pillai, Brian Hayes, Beverly Torok-Storb

Abstract read
In one paragraph

Article in Experimental hematology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Comprehensive analysis of myeloid reporter mice.bioRxiv : the preprint server for biology · 2025
    Article
  2. Article
  3. Article
  4. Differential association of CD68British journal of cancer · 2020
    Article
  5. Article
  6. Article
  7. Astrocytes and microglia: Models and tools.The Journal of experimental medicine · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Deletion of the murine scavenger receptor CD68.Journal of lipid research · 2011
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Manoj M PillaiClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Manoj.Pillai@UCDenver.edu
Brian Hayes
Beverly Torok-Storb

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Thomas James Lynch · 1985 to 2026
$296.4M
CORE--VECTOR PRODUCTIONP30DK056465 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HARKEY, MICHAEL A · 1999 to 2014
$14.9M
REGULATION OF HEMATOPOIESISR01HL062923 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TOROK-STORB, BEVERLY J. · 1998 to 2008
$3.0M
Monocyte derived CXCL7 in the marrow microenvironmentK08DK073701 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI PILLAI, MANOJ M. · 2006 to 2010
$641k
NCI NIH HHS P30 CA015704NCI NIH HHS P30CA015704NHLBI NIH HHS R01 HL062923NHLBI NIH HHS R01HL62923NIDDK NIH HHS K08 DK073701NIDDK NIH HHS P30 DK056465NIDDK NIH HHS P30DK56465
6 · The paper itself

Abstract

objectiveMacrophages are critical components of diverse microenvironments (ME) in adulthood, as well as during embryogenesis. Their role in development precludes the use of gene-targeting and knockout approaches for studying their function. Hence, we proposed to create a macrophage-specific inducible transgenic mouse where genes can be turned on or off at will. MATERIALS AND

methodsA transgenic mouse in which the reverse tetracycline activator (rtTA-M2) is expressed under the hCD68 promoter for macrophage-specific gene induction was developed and crossed with a second transgenic reporter mouse strain in which the gene for green fluorescent protein (GFP) is under the control of tetracycline responsive element promoter. After doxycycline induction of the double transgenic animals (designated CD68-rtTA-tet-GFP), inducible expression of GFP was characterized by multicolor flow cytometric analysis of blood, marrow, and spleen cells and by demonstration of GFP expression in fresh-frozen sections in diverse tissues.

resultsIn bone marrow, inducible GFP expression was not confined to, or inclusive of, all cells expressing the classical macrophage markers, such as F4/80. However, GFP-expressing cells in thioglycollate-elicited peritoneal macrophages were also positive for F4/80 and monocyte-macrophage-specific 2 antigen. Interestingly, flow analysis also indicated little overlap between the F4/80 and CSF-1R-positive populations. Fresh-frozen samples of tissues known to contain macrophages revealed GFP-expressing cells with variable morphologies.

conclusionOur results show that the hCD68 promoter directs gene expression in a macrophage population distinct from that defined by classical monocyte-macrophage markers or promoters. Whether this population is functionally distinct remains to be established.

Indexed as

AnimalsAntigens, CDAntigens, DifferentiationAntigens, Differentiation, MyelomonocyticCD68 MoleculeFemaleFlow CytometryGreen Fluorescent ProteinsHumansMacrophages, PeritonealMaleMiceMice, TransgenicMicroscopy, FluorescencePlacentaPregnancyAntigens, CDAntigens, DifferentiationAntigens, Differentiation, MyelomonocyticCD68 antigen, humanCD68 MoleculeGreen Fluorescent Proteinsmonocyte-macrophage differentiation antigenReceptor, Macrophage Colony-Stimulating Factor

Identifiers

PMID19772887
PMCPMC2925267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.